Search clinical trials for: NCT01949129 add-on

Total 33 results

St. Anna Kinderkrebsforschung
Assistance Publique - Hôpitaux de Paris; Australian & New Zealand Children's... and other collaborators

Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia

Italy, Israel, Spain, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Croatia, Czechia, Denmark, Finland, Greece, Malaysia, Mexico, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovakia, Sweden, Switzerland, Turkey, F... and more
Swiss Pediatric Oncology Group
ALL SCTped Forum

Recruiting

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Acute Lymphoblastic Leukemia

Switzerland
Fujian Medical University Union Hospital

Recruiting

Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension

Alzheimer Disease | Orthostatic Hypotension

China
National Cheng-Kung University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients

Bipolar II Disorder

Taiwan
Charite University, Berlin, Germany
Eli Lilly and Company

Withdrawn

Optimal Duration of Olanzapine Add-on Therapy in Major Depression (OLA-D)

Relapse Rate of a Major Depressive Episode | Safety of Olanzapine in Subjects With Major Depression

Germany
Je Bouge Pour Mon Moral
University Grenoble Alps

Completed

Physical Exercise and Depressive Symptoms in Moderately or Severely Depressed Adults (EXIMOS)

Depressive Symptoms

France
University Hospital Freiburg

Withdrawn

Aripiprazole Augmentation Therapy in Treatment-resistant Depression

Therapy-resistant Depression

Germany
University Hospital Freiburg

Withdrawn

Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial

Therapy-resistant Depression

Germany
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Unknown

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection

add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma

China
BDH-Klinik Hessisch Oldendorf

Withdrawn

rTMS as an add-on Therapy in Patients With Post-stroke Depression

Post-stroke Depression

Germany
Universiteit Antwerpen
Universitair Ziekenhuis Brussel

Unknown

Continuous Theta Burst Stimulation as an add-on Treatment for Bipolar Depression

Depression | Mood Disorders | Bipolar Disorder | Bipolar Depression | Mental Disorder | Bipolar I Disorder | Bipolar II Disorder

Belgium
UCB BIOSCIENCES, Inc.

Completed

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies

United States
University of Massachusetts, Worcester
Forest Laboratories

Completed

Memantine Augmentation of Antidepressants

Depressive Disorder

United States
Sheba Medical Center

Unknown

Add-on Methotrexate for the Treatment of Schizophrenia

Schizophrenia
National Cheng-Kung University Hospital

Unknown

Memantine in Bipolar Patients With Alcoholism

AOD Effects and Consequences

Taiwan
TCM Biotech International Corp.

Withdrawn

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Chronic Hepatitis C

Taiwan, China
Novartis

Completed

Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy

Type 2 Diabetes Mellitus

China
Bayer

Terminated

Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients

Colitis, Ulcerative

Germany
GlaxoSmithKline

Completed

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

Schizophrenia

United States, Canada, United Kingdom
Italian Society of Diabetology
Associazione Nazionale Medici Cardiologi Ospedalieri; Associazione Medici Diabetologi...

Unknown

Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial (TOSCA IT)

Cardiovascular Disease | Type 2 Diabetes Mellitus

Italy
UCB Pharma

Completed

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (PASS)

Epilepsies, Partial

France, Germany, United Kingdom, Spain, Netherlands
TCM Biotech International Corp.

Completed

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection (TCM-700C)

Chronic Hepatitis C

Taiwan
Ib Abildgaard Jacobsen

Completed

Amiloride for Resistant Hypertension

Hypertension | Type 2 Diabetes Mellitus | Microalbuminuria

Denmark
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India, Puerto Rico
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

Sweden, Czech Republic, Poland, Germany, Estonia, Latvia, Lithuania, Finland, France, Hungary
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder | MDD

United States, Puerto Rico
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Depression | Major Depressive Disorder

United States, India
Institut fuer anwendungsorientierte Forschung und...

Completed

Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

Optic Neuritis

Germany
Mclean Hospital

Withdrawn

Prazosin as an Antimanic Agent in Severe Mania or Mixed States

Bipolar, Mania | Bipolar, Mixed State
Sunnybrook Health Sciences Centre

Completed

Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

Subjects Had Unipolar, Non-psychotic Major Depression

Canada
Hanoi Medical University
Karolinska Institutet; Swedish International Development Cooperation Agency...

Completed

Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients

Type 2 Diabetes

Vietnam
Rambam Health Care Campus
Beersheva Mental Health Center

Completed

Tryptophan Depletion in Acute Mania

Bipolar Disorder

Israel

Search clinical trials for: NCT01949129 add-on

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations